Firm
Firms in Canada explain how they’ve adapted to a rule change in 2017 that has made advocacy skills more important in pharma disputes
Leaders at some IP businesses are looking to consolidate the fragmented market and, considering the benefits, their rivals may want to follow suit
Counsel at three US firms explain how they are expanding their UPC teams or if they are looking to partner with European firms
Lucy Wheatley, partner at McGuireWoods, discusses the challenges of explaining trademarks to a jury and reveals a logistical hurdle she had to navigate
Sponsored
Sponsored
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners discusses the consequences of a judgment from an Osaka court on direct and indirect patent infringement of overseas knockdown production -
Sponsored by Liu Shen & AssociatesGuanyang Yao, Yali Shao and Yuan Zhang of Liu Shen & Associates provide a practical insight into the 4th amended Patent Law in China
-
Sponsored by Wanhuida Intellectual PropertyJianhui Li and Honghui Hu of Wanhuida Intellectual Property discuss the antitrust scrutiny of China’s Supreme People’s Court in a patent infringement appeal concerning reverse payment settlement agreement
-
Sponsored by Han Kun Law OfficesXiaowei Wei and Lili Wu of Han Kun Law Offices review the guidelines for patent examination in China and propose potential strategies going forward
-
Sponsored by Purplevine IPXiaojuan Yu of Purplevine IP Group discusses the medical device industry in China and considers why changes to the law are welcomed
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos P/S discusses the Unitary Patent and Unified Patent Court regime expected to enter into force by early 2023
